A
Active Biotech AB publ
STO:ACTI
Active Biotech AB publ
STO:ACTI
Price:
0.0433
SEK
1.17%
Market Closed
Market Cap:
kr114.1m
Balance Sheet
Balance Sheet Decomposition
Active Biotech AB publ
Active Biotech AB publ
Balance Sheet Decomposition is not available for
Active Biotech AB publ
Active Biotech AB publ
Balance Sheet
Active Biotech AB publ
Active Biotech AB publ
Currency: SEK
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
169
|
45
|
211
|
178
|
98
|
139
|
139
|
156
|
131
|
465
|
217
|
376
|
328
|
104
|
78
|
25
|
26
|
60
|
26
|
53
|
42
|
36
|
27
|
65
|
|
| Cash Equivalents |
169
|
45
|
211
|
178
|
98
|
139
|
139
|
156
|
131
|
465
|
217
|
376
|
328
|
104
|
78
|
25
|
26
|
60
|
26
|
53
|
42
|
36
|
27
|
65
|
|
| Short-Term Investments |
160
|
182
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
18
|
13
|
7
|
6
|
8
|
9
|
7
|
12
|
7
|
4
|
93
|
7
|
9
|
14
|
5
|
3
|
2
|
3
|
2
|
1
|
1
|
1
|
9
|
3
|
|
| Accounts Receivables |
4
|
3
|
1
|
2
|
1
|
2
|
2
|
1
|
0
|
1
|
89
|
3
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
14
|
10
|
6
|
5
|
7
|
8
|
5
|
12
|
7
|
3
|
4
|
4
|
9
|
13
|
4
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
13
|
10
|
9
|
3
|
6
|
10
|
3
|
12
|
7
|
7
|
6
|
4
|
3
|
2
|
2
|
274
|
274
|
1
|
3
|
2
|
1
|
1
|
2
|
0
|
|
| Total Current Assets |
359
|
250
|
230
|
188
|
112
|
157
|
148
|
180
|
145
|
476
|
315
|
387
|
341
|
120
|
85
|
302
|
301
|
64
|
30
|
56
|
44
|
39
|
39
|
68
|
|
| PP&E Net |
60
|
50
|
39
|
377
|
348
|
330
|
325
|
319
|
359
|
383
|
382
|
381
|
382
|
330
|
328
|
2
|
1
|
3
|
2
|
1
|
6
|
5
|
3
|
2
|
|
| PP&E Gross |
60
|
50
|
39
|
377
|
348
|
330
|
325
|
319
|
359
|
383
|
382
|
381
|
382
|
330
|
328
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
90
|
105
|
118
|
127
|
147
|
166
|
177
|
158
|
174
|
186
|
199
|
211
|
223
|
141
|
153
|
50
|
50
|
800
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
3
|
2
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
45
|
43
|
42
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
468
N/A
|
345
-26%
|
313
-9%
|
568
+81%
|
462
-19%
|
490
+6%
|
473
-3%
|
499
+5%
|
503
+1%
|
859
+71%
|
697
-19%
|
768
+10%
|
723
-6%
|
449
-38%
|
413
-8%
|
304
-26%
|
302
0%
|
67
-78%
|
32
-52%
|
57
+77%
|
51
-10%
|
44
-14%
|
43
-2%
|
70
+63%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
33
|
25
|
15
|
7
|
14
|
10
|
16
|
13
|
28
|
28
|
42
|
34
|
24
|
7
|
4
|
4
|
4
|
6
|
3
|
3
|
4
|
3
|
1
|
0
|
|
| Accrued Liabilities |
20
|
18
|
28
|
21
|
27
|
32
|
32
|
28
|
36
|
73
|
67
|
91
|
61
|
37
|
9
|
11
|
6
|
4
|
5
|
6
|
7
|
5
|
6
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
27
|
2
|
2
|
6
|
104
|
6
|
7
|
8
|
8
|
8
|
8
|
7
|
7
|
6
|
9
|
210
|
204
|
1
|
1
|
1
|
2
|
2
|
2
|
0
|
|
| Other Current Liabilities |
5
|
6
|
7
|
2
|
2
|
2
|
3
|
14
|
8
|
13
|
11
|
6
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| Total Current Liabilities |
85
|
51
|
52
|
36
|
147
|
49
|
58
|
62
|
80
|
122
|
128
|
138
|
95
|
53
|
23
|
226
|
214
|
11
|
9
|
10
|
12
|
10
|
9
|
15
|
|
| Long-Term Debt |
0
|
5
|
99
|
355
|
255
|
251
|
252
|
248
|
242
|
235
|
229
|
224
|
223
|
216
|
207
|
0
|
0
|
2
|
1
|
0
|
4
|
3
|
2
|
0
|
|
| Other Liabilities |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
87
N/A
|
56
-36%
|
151
+170%
|
391
+160%
|
402
+3%
|
300
-25%
|
309
+3%
|
310
+0%
|
321
+4%
|
357
+11%
|
357
+0%
|
362
+2%
|
317
-12%
|
269
-15%
|
230
-14%
|
226
-2%
|
215
-5%
|
13
-94%
|
10
-24%
|
10
+1%
|
16
+63%
|
13
-19%
|
10
-22%
|
15
+40%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
281
|
337
|
337
|
396
|
150
|
178
|
193
|
241
|
249
|
260
|
260
|
282
|
282
|
339
|
365
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
6
|
0
|
|
| Retained Earnings |
99
|
48
|
175
|
1 596
|
1 718
|
1 922
|
2 102
|
2 326
|
2 512
|
2 581
|
2 743
|
2 947
|
3 171
|
3 396
|
3 447
|
3 188
|
3 225
|
3 259
|
3 291
|
3 340
|
3 398
|
3 443
|
3 483
|
0
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1 377
|
1 628
|
1 933
|
2 072
|
2 273
|
2 445
|
2 823
|
2 823
|
3 070
|
3 294
|
3 237
|
3 265
|
3 265
|
3 312
|
3 312
|
3 312
|
3 386
|
3 431
|
3 472
|
3 509
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
33
|
56
|
|
| Total Equity |
380
N/A
|
290
-24%
|
162
-44%
|
177
+9%
|
60
-66%
|
190
+214%
|
164
-14%
|
189
+15%
|
182
-4%
|
502
+176%
|
340
-32%
|
405
+19%
|
405
0%
|
181
-55%
|
183
+1%
|
78
-57%
|
88
+13%
|
54
-39%
|
22
-59%
|
47
+111%
|
35
-26%
|
31
-11%
|
33
+7%
|
56
+70%
|
|
| Total Liabilities & Equity |
468
N/A
|
345
-26%
|
313
-9%
|
568
+81%
|
462
-19%
|
490
+6%
|
473
-3%
|
499
+5%
|
503
+1%
|
859
+71%
|
697
-19%
|
768
+10%
|
723
-6%
|
449
-38%
|
413
-8%
|
304
-26%
|
302
0%
|
67
-78%
|
32
-52%
|
57
+77%
|
51
-10%
|
44
-14%
|
43
-2%
|
70
+63%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
16
|
59
|
59
|
67
|
66
|
79
|
85
|
92
|
95
|
99
|
99
|
101
|
101
|
145
|
160
|
160
|
180
|
180
|
201
|
560
|
823
|
1 010
|
1 343
|
2 636
|
|
Switch to:
Switch to:
See Also
Discover More
